Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Automated Cyclosporine Immunoassay is Simple and Reliable

By HospiMedica staff writers
Posted on 28 Aug 2007
A highly specific automated immunoassay for cyclosporine has been developed for routine use.

The cyclosporine assay is integrated onto a random access immunoassay analyzer, the Advia Centaur system. More...
This reduces the need for multiple analyzers in the lab and saves operational and maintenance time for lab professionals. Engineered to provide "always ready” automation with STAT availability for rapid turnaround, the Advia Centaur does not require operator intervention for repeat requirements.

Introduced by Siemens Medical Solutions Diagnostics (Tarrytown, NY, USA), the Advia Centaur cyclosporine assay allows laboratory professionals to mainstream testing into routine workflow with a simplified extraction process and fully automated processing yielding an 18-minute turnaround time. The Advia Centaur assay's expansive linear range reduces the need for dilutions, reducing the time required for testing and the associated cost. The system features one-tube processing, thereby reducing the need for labor-intensive pipetting, and deliver hundreds of test results per hour. Fully prepared reagents are available to laboratory professionals in a ReadyPack format.

The cyclosporine assay system provides lab professionals with reliable results and physicians with the information they need to optimize patient management. Engineered to provide "always ready” automation with STAT availability for rapid turnaround, the Advia Centaur does not require operator intervention for repeat requirements.

"The ADVIA Centaur Cyclosporine assay shows excellent correlation with the gold standard tandem mass spectrometric method,” said Steven J. Soldin, Ph.D., director, bioanalytical core laboratory, Georgetown University (Washington, DC, USA) and the clinical chemistry laboratories at Children's National Medical Center (Washington, DC, USA). "This method has very good reproducibility and a wide linear range that can accommodate both C0 and C2 testing protocols. In addition, this new cyclosporine assay has little metabolite cross-reactivity.”

"The cyclosporine assay marks Siemens Diagnostics' entry into immunosuppressant drug monitoring, a critical area of healthcare,” said Joe Bernardo, senior vice president, Central Lab Testing, Siemens Medical Solutions Diagnostics. "The release of the cyclosporine assay is an example of how Siemens is utilizing its expertise and resources to expand an already comprehensive, disease focused menu.”


Related Links:
Siemens Medical Solutions Diagnostics
Georgetown University
Children's National Medical Center

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Medical Monitor
VITALMAX 4100SL
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.